Clinical Trial Update: Study to Evaluate CCS1477 in Advanced Tumours [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of CCS1477 has completed, evaluating it in metastatic castration-resistant prostate cancer and metastatic breast cancer, with non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Castration-resistant Prostate Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• CCS1477

Snippet

Sponsor: CellCentric Ltd. | Conditions: Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED